TXMD
Therapeuticsmd Inc
NASDAQ · Pharmaceuticals
$2.29
+0.10 (+4.57%)
Open$2.23
Previous Close$2.19
Day High$2.32
Day Low$2.19
52W High$13.60
52W Low$8.21
Volume—
Avg Volume456.5K
Market Cap26.51M
P/E Ratio19.01
EPS$0.56
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+418.8% upside
Current
$2.29
$2.29
Target
$11.88
$11.88
$7.57
$11.88 avg
$17.16
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 5.35M | 4.86M | 6.01M |
| Net Income | 1.38M | 1.27M | 1.34M |
| Profit Margin | 25.7% | 26.2% | 22.4% |
| EBITDA | 2.60M | 2.17M | 2.73M |
| Free Cash Flow | 1.75M | 1.08M | 1.44M |
| Rev Growth | +2.2% | +8.5% | +15.2% |
| Debt/Equity | 0.57 | 0.57 | 0.69 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |